Covington & Burling advised Insmed Incorporated on the transaction. Insmed Incorporated (Nasdaq: INSM) (“Insmed”) announced its entrance into an agreement to amend its $350 million term...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Omeros Corporation on the deal, and King & Spalding and Paul Hastings represented the lenders. Omeros Corporation (Omeros) (Nasdaq: OMER) announced it...
You must be a Standard 1 Year member to access this content.
Covington represented the underwriters on the deal. Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders,...
You must be a Standard 1 Year member to access this content.
Covington advised Insmed Incorporated on the deal while Fenwick represented Pharmakon. Walder Wyss advised the funds managed by Pharmakon Advisors, LP, BioPharma Credit and OrbiMed. Akin...
You must be a Standard 1 Year member to access this content.
White & Case advised AMCI, Covington & Burling advised LanzaTech, Ropes & Gray advised the placement agents on the deal. AMCI Acquisition Corp. II, a publicly...
You must be a Standard 1 Year member to access this content.
